Active Ingredient (In Each Tablet)
Loratadine, USP 10 mg
The following Structured Product Label (SPL) was submitted to the FDA by State Of Florida Doh Central Pharmacy for the product Loratadine (NDC 53808-0457). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, how supplied, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Loratadine, USP 10 mg
Antihistamine
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
They are supplied by State of Florida DOH Central Pharmacy as follows:
| NDC | Strength | Quantity/Form | Color | Source Prod. Code |
| 53808-0457-1 | 10 mg | 30 Tablets in a Blister Pack | WHITE | 45802-0650 |
if you have ever had an allergic reaction to this product or any of its ingredients.
liver or kidney disease.Your doctor should determine if you need a different dose.
do not take more than directed. Taking more than directed may cause drowsiness.
if an allergic reaction to this product occurs. Seek medical help right away.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
Lactose monohydrate, magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
1 800 719-9260
NDC 53808-0457-1 Non-Drowsy*
LORAtadine
Tablets, USP
10 mg
Antihistamine
Indoor & Outdoor Allergies
24 Hour
Relief of:
• Sneezing
• Runny Nose
• Itchy, Watery
Eyes
• Itchy Throat
or Nose
* When taken as directed.
See Drug Facts Panel.
* Please review the disclaimer below.